Meta-analysis to compare the accuracy of GeneXpert, MODS and the WHO 2007 algorithm for diagnosis of smear-negative pulmonary tuberculosis

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Walusimbi, Simon ^a,b   Bwanga, Freddie ^a   De Costa, Ayesha ^b   Haile, Melles ^b,c   Joloba, Moses ^a   Hoffner, Sven ^c  

^a MAKERERE UNIVERSITY   (Uganda)

^b KAROLINSKA INSTITUTE   (Sweden)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

GeneXpert; MODS; Pulmonary TB; Smear negative; WHO TB algorithm

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST ACCURACY STUDY; FALSE POSITIVE RESULT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; META ANALYSIS; POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; ADULT; ALGORITHM; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MICROSCOPY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SPUTUM; THORAX RADIOGRAPHY; TUBERCULOSIS, PULMONARY;

ADULT; ALGORITHMS; FEMALE; HUMANS; MALE; MICROSCOPY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; RADIOGRAPHY, THORACIC; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84886470418     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-507     Document Type: Article

References (53)

1. World Health Organization Global Tuberculosis Report 2012, Available from: http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf. Accessed on August 2013, World Health Organization.
2. Steingart KR, Ng V, Henry M, Hopewell PC, Ramsay A, Cunningham J, Urbanczik R, Perkins MD, Aziz MA, Pai M. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006, 6(10):664-674. 10.1016/S1473-3099(06)70602-8, 17008175.
3. Steingart KR, Henry M, Ng V, Hopewell PC, Ramsay A, Cunningham J, Urbanczik R, Perkins M, Aziz MA, Pai M. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006, 6(9):570-581. 10.1016/S1473-3099(06)70578-3, 16931408.
4. Murray JF. Pulmonary complications of HIV-1 infection among adults living in Sub-Saharan Africa. Int J Tuberc Lung Dis 2005, 9(8):826-835.
5. Getahun H, Harrington M, O'Brien R, Nunn P. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes. Lancet 2007, 369(9578):2042-2049. 10.1016/S0140-6736(07)60284-0, 17574096.
6. World Health Organization Improving the diagnosis and treatment of smear-negative pulmonary and extrapulmonary tuberculosis among adults and adolescents. Recommendations for HIV-prevalent and resource-constrained settings. Stop TB 2007, Geneva: Department of HIV/AIDS, Available from: http://whqlibdoc.who.int/hq/2007/WHO_HTM_TB_2007.379_eng.pdf. Accessed August 2013, World Health Organization.
7. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010, 16(3):271-284.
8. Alamo ST, Kunutsor S, Walley J, Thoulass J, Evans M, Muchuro S, Matovu A, Katabira E. Performance of the new WHO diagnostic algorithm for smear-negative pulmonary tuberculosis in HIV prevalent settings: a multisite study in Uganda. Trop Med Int Health 2012, 17(7):884-895. 10.1111/j.1365-3156.2012.03003.x, 22575012.
9. World Health Organization Rapid implementation of the Xpert MTB/RIF diagnostic test: technical and operational "How-to"; practical considerations. 2011, Available from: http://whqlibdoc.who.int/publications/2011/9789241501569_eng.pdf. Accessed August 2013, World Health Organization.
10. Blakemore R, Story E, Helb D, Kop J, Banada P, Owens MR, Chakravorty S, Jones M, Alland D. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010, 48(7):2495-2501. 10.1128/JCM.00128-10, 2897495, 20504986.
11. World Health Organization Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert mtb/rif system. Policy statement 2011 2011, Available from: http://whqlibdoc.who.int/publications/2011/9789241501545_eng.pdf. Accessed August 2013., World Health Organization.
12. World Health Organization Noncommercial culture and drug-susceptibility testing methods for screening patients at risk for multidrug- resistant tuberculosis. Policy statement 2011 Available from: http://whqlibdoc.who.int/publications/2011/9789241501620_eng.pdf. Accessed August 2013, World Health Organization.
13. Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, Lee EH, Berg DE, Montenegro-James S. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000, 38(3):1203-1208. 86377, 10699023.
14. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, Sanchez E, Pinedo Y, Saravia JC, Salazar C, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006, 355(15):1539-1550. 10.1056/NEJMoa055524, 1780278, 17035648.
15. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155(8):529-536. 10.7326/0003-4819-155-8-201110180-00009, 22007046.
16. Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006, 6:31. 10.1186/1471-2288-6-31, 1552081, 16836745.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21(11):1539-1558. 10.1002/sim.1186, 12111919.
18. Identifying and measuring heterogeneity Available at http://handbook.cochrane.org/chapter_9/9_5_2_identifying_and_measuring_heterogeneity.htm. Accessed August 12.
19. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: a new meta-analytic method. Med Decis Making 1993, 13(4):313-321. 10.1177/0272989X9301300408, 8246704.
20. Moses LE, Shapiro D, Littenberg B. Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 1993, 12(14):1293-1316. 10.1002/sim.4780121403, 8210827.
21. Colton T. Statistics in Medicine 1974, Little, Brown and Company: Boston.
22. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363(11):1005-1015. 10.1056/NEJMoa0907847, 2947799, 20825313.
23. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377(9776):1495-1505. 10.1016/S0140-6736(11)60438-8, 3085933, 21507477.
24. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010, 48(1):229-237. 10.1128/JCM.01463-09, 2812290, 19864480.
25. Malbruny B, Le Marrec G, Courageux K, Leclercq R, Cattoir V. Rapid and efficient detection of Mycobacterium tuberculosis in respiratory and non-respiratory samples. Int J Tuberc Lung Dis 2011, 15(4):553-555. 10.5588/ijtld.10.0497, 21396219.
26. Bowles EC, Freyee B, van Ingen J, Mulder B, Boeree MJ, van Soolingen D. Xpert MTB/RIF(R), a novel automated polymerase chain reaction-based tool for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 2011, 15(7):988-989. 10.5588/ijtld.10.0574, 21682978.
27. Moure R, Munoz L, Torres M, Santin M, Martin R, Alcaide F. Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real-time PCR method. J Clin Microbiol 2011, 49(3):1137-1139. 10.1128/JCM.01831-10, 3067676, 21191053.
28. Marlowe EM, Novak-Weekley SM, Cumpio J, Sharp SE, Momeny MA, Babst A, Carlson JS, Kawamura M, Pandori M. Evaluation of the Cepheid Xpert MTB/RIF assay for direct detection of Mycobacterium tuberculosis complex in respiratory specimens. J Clin Microbiol 2011, 49(4):1621-1623. 10.1128/JCM.02214-10, 3122817, 21289151.
29. Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011, 184(1):132-140. 10.1164/rccm.201101-0056OC, 21493734.
30. Rachow A, Zumla A, Heinrich N, Rojas-Ponce G, Mtafya B, Reither K, Ntinginya EN, O'Grady J, Huggett J, Dheda K, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay-a clinical validation study. PLoS One 2011, 6(6):e20458. 10.1371/journal.pone.0020458, 3126807, 21738575.
31. Scott LE, McCarthy K, Gous N, Nduna M, Van Rie A, Sanne I, Venter WF, Duse A, Stevens W. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. PLoS Med 2011, 8(7):e1001061. 10.1371/journal.pmed.1001061, 3144192, 21814495.
32. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011, 8(7):e1001067. 10.1371/journal.pmed.1001067, 3144215, 21818180.
33. Ioannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, Raftopoulou E, Konstantinidou E, Marinou I, Kanavaki S. Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol 2011, 49(8):3068-3070. 10.1128/JCM.00718-11, 3147726, 21677069.
34. Miller MB, Popowitch EB, Backlund MG, Ager EP. Performance of Xpert MTB/RIF RUO assay and IS6110 real-time PCR for Mycobacterium tuberculosis detection in clinical samples. J Clin Microbiol 2011, 49(10):3458-3462. 10.1128/JCM.05212-11, 3187315, 21849695.
35. Teo J, Jureen R, Chiang D, Chan D, Lin R. Comparison of two nucleic acid amplification assays, the Xpert MTB/RIF assay and the amplified Mycobacterium Tuberculosis Direct assay, for detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 2011, 49(10):3659-3662. 10.1128/JCM.00211-11, 3187313, 21865419.
36. Nicol MP, Workman L, Isaacs W, Munro J, Black F, Eley B, Boehme CC, Zemanay W, Zar HJ. Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. Lancet Infect Dis 2011, 11(11):819-824. 10.1016/S1473-3099(11)70167-0, 21764384.
37. Rachow A, Clowes P, Saathoff E, Mtafya B, Michael E, Ntinginya EN, Kowour D, Rojas-Ponce G, Kroidl A, Maboko L, et al. Increased and expedited case detection by Xpert MTB/RIF assay in childhood tuberculosis: a prospective cohort study. Clin Infect Dis 2012, 54(10):1388-1396. 10.1093/cid/cis190, 22474220.
38. Safianowska A, Walkiewicz R, Nejman-Gryz P, Grubek-Jaworska H. Two selected commercially based nucleic acid amplification tests for the diagnosis of tuberculosis. Pneumonol Alergol Pol 2012, 80(1):6-12.
39. Arias M, Mello FC, Pavon A, Marsico AG, Alvarado-Galvez C, Rosales S, Pessoa CL, Perez M, Andrade MK, Kritski AL, et al. Clinical evaluation of the microscopic-observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007, 44(5):674-680. 10.1086/511639, 17278058.
40. Mashta A, Mishra P, Philipose S, Tamilzhalagan S, Mahmud H, Bhaskar S, Upadhyay P. Diagnosis of tuberculosis: the experience at a specialized diagnostic laboratory. J Negat Results Biomed 2011, 10:16. 10.1186/1477-5751-10-16, 3228662, 22093248.
41. Shah NS, Moodley P, Babaria P, Moodley S, Ramtahal M, Richardson J, Heysell S, Li X, Moll A, Friedland G, et al. Rapid diagnosis of tuberculosis and multidrug resistance by the microscopic-observation drug-susceptibility assay. Am J Respir Crit Care Med 2011, 183(10):1427-1433. 10.1164/rccm.201009-1449OC, 21297071.
42. Ha DT, Lan NT, Kiet VS, Wolbers M, Hang HT, Day J, Hien NQ, Tien NA, An PT, Anh TT, et al. Diagnosis of pulmonary tuberculosis in HIV-positive patients by microscopic observation drug susceptibility assay. J Clin Microbiol 2010, 48(12):4573-4579. 10.1128/JCM.00687-10, 3008451, 20926704.
43. Chaiyasirinroje B, Aung MN, Moolphate S, Kasetjaroen Y, Rienthong S, Rienthong D, Nampaisan O, Nedsuwan S, Sangchun W, Suriyon N, et al. Prospective evaluation of simply modified MODS assay: an effective tool for TB diagnosis and detection of MDR-TB. Infect Drug Resist 2012, 5:79-86. 3358813, 22629112.
44. Wilson D, Mbhele L, Badri M, Morroni C, Nachega J, Chaisson RE, Maartens G. Evaluation of the World Health Organization algorithm for the diagnosis of HIV-associated sputum smear-negative tuberculosis. Int J Tuberc Lung Dis 2011, 15(7):919-924. 10.5588/ijtld.10.0440, 21682965.
45. Swai HF, Mugusi FM, Mbwambo JK. Sputum smear negative pulmonary tuberculosis: sensitivity and specificity of diagnostic algorithm. BMC Res Notes 2011, 4:475. 10.1186/1756-0500-4-475, 3216301, 22044882.
46. Koole O, Thai S, Khun KE, Pe R, van Griensven J, Apers L, Van den Ende J, Mao TE, Lynen L. Evaluation of the 2007 WHO guideline to improve the diagnosis of tuberculosis in ambulatory HIV-positive adults. PLoS One 2011, 6(4):e18502. 10.1371/journal.pone.0018502, 3071837, 21494694.
47. Rosman AS, Korsten MA. Application of summary receiver operating characteristics (sroc) analysis to diagnostic clinical testing. Adv Med Sci 2007, 52:76-82.
48. WHO Fluorescent light-emitting diode (LED) microscopy for diagnosis of tuberculosis 2011, Policy statement, Available at http://www.ecdc.europa.eu/en/publications/Publications/1105_TER_Basics_TB_control.pdf. Accessed August 12. 2013, WHO.
49. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013, (1):CD009593. DOI:10.1002/14651858.CD009593.pub2. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009593.pub2/pdf. Accessed August 2013.
50. Chang K, Lu W, Wang J, Zhang K, Jia S, Li F, Deng S, Chen M. Rapid and effective diagnosis of tuberculosis and rifampicin resistance with Xpert MTB/RIF assay: a meta-analysis. J Infect 2012, 64(6):580-588. 10.1016/j.jinf.2012.02.012, 22381459.
51. Macaskill P, Gatsonis C, Deeks JJ, Harbord RM, Takwoingi Y. Chapter 10: Analysing and Presenting Results. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0 2010, Deeks JJ, Bossuyt PM, Gatsonis C, The Cochrane Collaboration, Available from: http://srdta.cochrane.org/. Accessed August 12-2013.
52. Bwanga F, Hoffner S, Haile M, Joloba ML. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009, 9:67. 10.1186/1471-2334-9-67, 2696456, 19457256.
53. Recommendations on testing for funnel plot asymmetry Available at http://handbook.cochrane.org/chapter_10/10_4_3_1_recommendations_on_testing_for_funnel_plot_asymmetry.htm. Accessed August 12. 2013.